FDA issues advisory on ADHD drug, Strattera
(November, 2005)

Guidance offered on self-administration of medication at school
(November, 2005)

Treatment of children with ITP relies on clinical experience
(October, 2005)

New AAP policy advises on emergency contraception use
(September, 2005)

Pediatricians armed with drug data serve patients better
(September, 2005)

Law prompts studies of drugs in children, label changes
(August 2005)

AAP answers congressional concerns over foster children in clinical trials
(July 2005)

Pimecrolimus shown to be effective anti-inflammatory agent
(July, 2005)

Prozac labeled as safe, effective for depression in children
(June, 2005)

E-prescribing can add quality, safety to patient care
(May, 2005)

FDA advises using 2 atopic dermatitis drugs only as labeled
(May, 2005)

Drug therapies for migraine outlined in AAP-endorsed parameter
(April, 2005)

Drug agency proposal could affect dispensing of stimulants
(March, 2005)

Fentanyl patch has restrictions for managing pain after surgery
(March, 2005)

Experts say data do not support changes in naproxen use
(February, 2005)

Physicians urged to detail benefits of medication delivery system
(February, 2005)

FDA strengthens monitoring of acne drug isotretinoin
(February, 2005)

E-prescribing: A modern way to manage patients medications
(February, 2005)

FDA issues statement on Adderall
(February, 2005)

Warnings added to phenergan label
(February, 2005)

Budesonide can cause systemic problems in young infants
(February, 2005)

Drug studies may help change core practices in neonatology
(January, 2005)

Modest results seen in treatment of obese teens with orlistat
(January, 2005)

.